51 results on '"menopausal hormone therapy"'
Search Results
2. Menopausal hormone therapy and incidence, mortality, and survival of breast cancer subtypes: a prospective cohort study
3. Menopausal Hormone Therapy in Women with Type 2 Diabetes Mellitus: An Updated Review
4. Menopausal hormone therapy and risk of sarcoidosis: a population-based nested case–control study in Sweden
5. Hormonal Therapies in Multiple Sclerosis: a Review of Clinical Data
6. Long-term breast cancer incidence trends by mammography, obesity, and menopausal hormone therapy
7. OOPHORECTOMY: When and Why? A Novel Risk Stratification Tool as an Aid to Decision Making at Gynecological Surgeries
8. Prevalence of menopausal symptoms and attitudes towards menopausal hormone therapy in women aged 40–60 years: a cross-sectional study
9. Exogenous female sex steroid hormones and new-onset asthma in women: a matched case–control study
10. The Relationship Between Sleep and Sexual Function in Women
11. Menopausal hormone therapy reduces the risk of fracture regardless of falls risk or baseline FRAX probability—results from the Women’s Health Initiative hormone therapy trials
12. Menopausal hormone therapy in women with dyslipidemia and nonalcoholic fatty liver disease
13. Accurate categorisation of menopausal status for research studies: a step-by-step guide and detailed algorithm considering age, self-reported menopause and factors potentially masking the occurrence of menopause
14. What is behind the fear of cancer during menopausal hormone therapy in China?
15. Menopausal Hormonal Therapy and Breast Cancer
16. Hormone und Knochenstoffwechsel
17. Nocturia through the menopausal transition and beyond: a narrative review
18. Estrogen and bones after menopause: a reappraisal of data and future perspectives
19. Hormonersatztherapie und vaskuläres Risiko: Kommentar zur Version 2.0 der AWMF-S3-Leitlinie „Peri- und Postmenopause – Diagnostik und Interventionen“ 2019
20. The effect of menopausal hormone therapy on gastrointestinal cancer risk and mortality in South Korea: a population-based cohort study
21. Association between menopausal hormone therapy, mammographic density and breast cancer risk: results from the E3N cohort study
22. Effect of CIMicifuga racemosa on metaBOLIC parameters in women with menopausal symptoms: a retrospective observational study (CIMBOLIC)
23. Hormone Replacement Therapy in Cancer Survivors – Review of the Literature
24. Hormonersatztherapie und vaskuläres Risiko: Kommentar zur Version 2.0 der AWMF-S3-Leitlinie „Peri- und Postmenopause – Diagnostik und Interventionen“ 2019
25. Type 2 Diabetes Mellitus and Menopausal Hormone Therapy: An Update
26. Menopausal hormone therapy and breast cancer risk: effect modification by body mass through life
27. Hormonersatztherapie und vaskuläres Risiko: Kommentar zur Version 2.0 der AWMF-S3-Leitlinie „Peri- und Postmenopause – Diagnostik und Interventionen“ 2019
28. Reproductive and menopausal factors and risk of second primary breast cancer after in situ breast carcinoma
29. Use of postmenopausal hormone therapies and risk of histology- and hormone receptor-defined breast cancer: results from a 15-year prospective analysis of NIH-AARP cohort
30. Menopausale Hormontherapie und Krebsrisiko
31. Estrogen–progestin use and breast cancer characteristics in lean and overweight postmenopausal women
32. Trends in hormone use and ovarian cancer incidence in US white and Australian women: implications for the future
33. Interactions between breast cancer susceptibility loci and menopausal hormone therapy in relationship to breast cancer in the Breast and Prostate Cancer Cohort Consortium
34. Relationship of Serum Estrogens and Metabolites with Area and Volume Mammographic Densities
35. Use of menopausal hormone therapy and risk of ductal and lobular breast cancer among women 55–74 years of age
36. Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort
37. Prolactin Receptor Expression and Breast Cancer: Relationships with Tumor Characteristics among Pre- and Post-menopausal Women in a Population-Based Case–Control Study from Poland
38. Is There a Role for Menopausal Hormone Therapy (MHT) for Cardiovascular Disease Prevention in Select Postmenopausal Women?
39. Prävention der postmenopausalen Osteoporose: Teil 2: Medikamentöse Prävention und Therapie der Osteoporose in der Peri- und frühen Postmenopause
40. Menopausal Hormone Therapy and Coronary Heart Disease: Reconciling Divergent Findings from Observational Studies and Clinical Trials
41. Occult Breast Tumor Reservoir: Biological Properties and Clinical Significance
42. Ovarian epithelial tumors and reproductive factors: a systematic review
43. A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication
44. Menopausal hormone therapy and risks of colorectal adenomas and cancers in the French E3N prospective cohort: true associations or bias?
45. Unopposed estrogen and estrogen plus progestin menopausal hormone therapy and lung cancer risk in the NIH–AARP Diet and Health Study Cohort
46. Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women’s health initiative clinical trials
47. Hormonal Manipulation Strategies in the Management of Menstrual Migraine and Other Hormonally Related Headaches
48. Reproductive factors, menopausal hormone therapy, and risk of non-Hodgkin, diffuse large B-cell and follicular lymphomas: a UK case–control study
49. Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women
50. Menopausal hormone therapy and new-onset diabetes in the French Etude Epidemiologique de Femmes de la Mutuelle Générale de l’Education Nationale (E3N) cohort
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.